Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aspreva Pharmaceuticals Corp (ASPV) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Aspreva Pharmaceuticals Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1314026.
Total stock buying since 2005: $7,650,395.
Total stock sales since 2005: $0.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2005-03 | 498,215 | $7,650,395 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2005-03-16 | Hbm Bioventures Cayman Ltd (10% Owner) | Buy | 32,215 | 12.83 | 413,415 |
| 2005-03-09 | Hbm Bioventures Cayman Ltd (10% Owner) | Buy | 466,000 | 15.53 | 7,236,980 |
Insider trading activities including stock purchases, stock sales, and option exercises of ASPV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aspreva Pharmaceuticals Corp (symbol ASPV, CIK number 1314026) see the Securities and Exchange Commission (SEC) website.